• Science & Technology

MRI scans help men avoid unnecessary prostate biopsy

MRI scans can identify around a quarter of men who have raised PSA levels but who do not have prostate cancer, according to new research. MRI scans can identify around a quarter of men who have raised PSA levels but who do not have prostate cancer, according to new research.

6 June 2016

• Health & Medicine

Staying on oestrogen-blocking drugs for five extra years 'prevents more breast cancers returning'

Women with the most common type of breast cancer could benefit from staying on key drugs for a decade, research suggests. Women with the most common type of breast cancer could benefit from staying on key drugs for a decade, research suggests.

6 June 2016

• Health & Medicine

Genetic chaos in tumours could predict responses to immunotherapy

Advanced bladder cancers have been shown to respond to a new immunotherapy drug when used as a patient’s first treatment. Advanced bladder cancers have been shown to respond to a new immunotherapy drug when used as a patient’s first treatment.

5 June 2016

• Health & Medicine

New pre-surgery technique may make colostomy bags redundant for emergency bowel cancer patients

An expandable tube that unblocks the bowel before surgery could lead to fewer cancer patients – diagnosed as emergencies – needing a colostomy bag. An expandable tube that unblocks the bowel before surgery could lead to fewer cancer patients – diagnosed as emergencies – needing a colostomy bag.

5 June 2016

• Health & Medicine

Twice a day radiotherapy halves treatment time and is equally good at treating small cell lung cancer

Having radiotherapy once a day for six and a half weeks or twice a day for three weeks – with chemotherapy – is equally good at treating small cell lung cancer. Having radiotherapy once a day for six and a half weeks or twice a day for three weeks – with chemotherapy – is equally good at treating small cell lung cancer.

5 June 2016

• Health & Medicine

Doubling-up on cancer immunotherapy shows promise, but side effects still a challenge

A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer. A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.

4 June 2016

• Science & Technology
• Health & Medicine

Defining cancers based on genetic ‘fingerprint’ could help personalise treatment

Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace. Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace.

4 June 2016

• Science & Technology
• Health & Medicine

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years. Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

3 June 2016

• Health & Medicine

Cancer Research UK trial shows improved 5 year survival for pancreatic cancer patients

An extra 13 percent of pancreatic cancer patients will live for at least five years when given a combination of chemotherapy drugs. An extra 13 percent of pancreatic cancer patients will live for at least five years when given a combination of chemotherapy drugs.

3 June 2016

• Health & Medicine

Let the right ones in – boosting immunotherapy for pancreatic cancer

Research published today in Cancer Cell might open up a way through pancreatic tumours’ defences. Research published today in Cancer Cell might open up a way through pancreatic tumours’ defences.

2 June 2016

• Health & Medicine

NICE given grant to research patient preference

NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK. NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK.

2 June 2016

• Health & Medicine

Scientists tear down pancreatic cancer's defences

Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs. Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs.

2 June 2016